Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Video game-based technologies allow new insight into memory, perception and motor control

New tools inspired by video games are revealing how the brain senses and responds to its surroundings, finds new human and animal research. Taking advantage of state-of-the art technologies to track and mimic real-life environments, these studies show with new detail how the brain navigates, identifies, and remembers a setting. In additional human research, scientists apply these same technological advances to help people who have experienced strokes regain skills.

17 Nov 2010

Warfarin taken along with herbal, dietary supplements may be dangerous

Herbal and dietary supplements are popular. People claim they make their joints feel better, their bones stronger, and their hearts healthier. But a recent study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City shows that many of these people may not realize their favorite supplement, mixed with prescription medications, may be putting their lives in danger, especially if they are taking warfarin - a blood-thinning medication commonly prescribed to patients living with atrial fibrillation to lower their risk of stroke.

17 Nov 2010

TexanPlus HMO provides affordable access to cholesterol-lowering prescription drugs

TexanPlus HMO powered by CCRx, a Medicare Advantage plan offered through the Universal American's family of healthcare companies, will provide broad and affordable access to LIPITOR and CRESTOR, two popular cholesterol-lowering prescription drugs.

17 Nov 2010

Perivascular adipose tissue may lead to cardiovascular disease: Research

Researchers at the University of Cincinnati (UC) have found that fat around the outside of arteries may lead to the development of cardiovascular disease and could be linked to its onset in individuals with diabetes.

17 Nov 2010

LRI pleased with FDA Advisory Committee's approval of Benlysta for lupus

The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased with the U.S. Food and Drug Administration (FDA) Advisory Committee's vote to recommend approval of Benlysta® for active systemic lupus erythematosus (SLE), offering patients new found hope for the first approved treatment option in more than 50 years.

17 Nov 2010

Scientists determine ways to stop damage, promote neuronal growth in spinal cord injury

If researchers could determine how to send signals to cells responding to a spinal cord injury, they might be able to stop one type of cell from doing additional damage at the injury site and instead, coax it into helping nerve cells grow.

17 Nov 2010

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

New results from an observational substudy from TRITON–TIMI 38 presented today at the American Heart Association (AHA) Scientific Sessions annual meeting showed that patients treated with Efient/Effient (prasugrel) prior to coronary artery bypass graft surgery (CABG) had a reduced overall mortality rate compared to patients treated with Plavix (clopidogrel)

17 Nov 2010

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.

17 Nov 2010

Omron supports American Heart Association's educational initiatives for hypertension treatment

Omron Healthcare today announced support for the American Heart Association's broad-based healthcare awareness campaign that will educate providers on hypertension treatment recommendations, including home blood pressure monitoring and best practices for integrating this into their standard of care.

16 Nov 2010

Stem cells for stroke: Clinical trial commences

Researchers have started the world’s first clinical trial of stem cells to treat stroke victims in Glasgow. The trial is undertaken by ReNeuron, a Guildford-based biotech company and started this weekend with an elderly man receiving an injection of 2 million stem cells into his brain. It received final approval to go ahead this year.

16 Nov 2010

Risk reduction of 20 ailments with regular exercise: Review

In a review article researchers have concluded that regular exercise cuts the risk of more than 20 illnesses. Some of these include colon cancer, heart disease, diabetes, osteoporosis and stroke said the study published in the International Journal of Clinical Practice.

16 Nov 2010

Anti-stroke blood thinner shows promise in large clinical trials

In new and extensive clinical trials an experimental blood thinner called rivaroxaban is at least as good at preventing strokes as the drug warfarin – that has been the most widely used agent for the past five decades in people with erratic heartbeats called atrial fibrillations. Researchers said this Monday that this drug also sharply reduces the risk of major bleeding that is seen with warfarin.

16 Nov 2010

Gore REDUCE Clinical Study investigates PFO in stroke patients

W. L. Gore & Associates today joined the US principal investigators for the Gore REDUCE Clinical Study in reaffirming their commitment to the study of Patent Foramen Ovale (PFO) in stroke patients using the GORE HELEX Septal Occluder.

16 Nov 2010

Canadian government announces new research initiative on childhood obesity

The Honourable Leona Aglukkaq, Minister of Health, today announced new initiatives for research on physical activity and childhood obesity through the Canadian Institutes of Health Research (CIHR).

16 Nov 2010

KINARM Assessment Station to help healthcare workers assess patients suffering from brain injuries

A Queen's University neuroscientist is launching a medical tool at the world's largest neuroscience conference in San Diego on Monday, Nov. 15.

16 Nov 2010

St. Jude presents results from ASSERT trial for stroke at American Heart Association

St. Jude Medical, Inc., a global medical device company, today announced the results of the ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), a St. Jude Medical sponsored trial conducted by the Population Health Research Institute of McMaster University and Hamilton Health Sciences in Hamilton, Canada.

16 Nov 2010

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).

16 Nov 2010

Stroke News and Research

Further Reading

Video game-based technologies allow new insight into memory, perception and motor control

Warfarin taken along with herbal, dietary supplements may be dangerous

TexanPlus HMO provides affordable access to cholesterol-lowering prescription drugs

Perivascular adipose tissue may lead to cardiovascular disease: Research

LRI pleased with FDA Advisory Committee's approval of Benlysta for lupus

Scientists determine ways to stop damage, promote neuronal growth in spinal cord injury

TRITON–TIMI 38 substudy shows prasugrel reduces overall mortality rate in ACS patients

JDRF, Amylin collaborate to support metreleptin study for type 1 diabetes

Omron supports American Heart Association's educational initiatives for hypertension treatment

Stem cells for stroke: Clinical trial commences

Risk reduction of 20 ailments with regular exercise: Review

Anti-stroke blood thinner shows promise in large clinical trials

Gore REDUCE Clinical Study investigates PFO in stroke patients

Canadian government announces new research initiative on childhood obesity

KINARM Assessment Station to help healthcare workers assess patients suffering from brain injuries

St. Jude presents results from ASSERT trial for stroke at American Heart Association

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Research suggests targeting spleen may promote healing of spinal cord injury

Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association

diaDexus third quarter revenue increases 26% to $3.2 million

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News